PUNEET SINGLA: Open Payments
NPI 1558596429 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,075 in 57 payments from 7 companies in 2025. Trend: 2023 $450 · 2024 $10,861 · 2025 $13,075
Speaker / faculty: $11,760Food & beverage: $1,285Travel & lodging: $30
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 42 | $12,449 |
| E.R. Squibb & Sons, L.L.C. | 9 | $336 |
| ABBVIE INC. | 1 | $115 |
| Neurocrine BioSciences, Inc. | 1 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: UZEDY, COBENFY, VRAYLAR, INGREZZA, CAPLYTA, ABILIFY ASIMTUFII, Auvelity, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
